Caitong International Asset Management »

Eupraxia Pharmaceuticals shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $7 1 7.00

More positions owned by Caitong International Asset Management

Lumentum Hldgs (LITE)
Axt (AXTI)
Venture Global Com Cl A (VG)
Marvell Technology (MRVL)
Palantir Technologies Cl A (PLTR)
Petroleo Brasileiro S A Sponsored Adr (PBR)
Exxon Mobil Corporation (XOM)
CF Industries Holdings (CF)
Cheniere Energy Com New (LNG)
Petroleo Brasileiro S A Sp Adr Non Vtg (PBR.A)
Lam Research Corp Com New (LRCX)
Chevron Corporation (CVX)
SLB Com Stk (SLB)
Visa Com Cl A (V)
Apple (AAPL)

View all positions for Caitong International Asset Management

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Balyasny Asset Management
Vivo Capital
Scotia Capital
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
UBS Group
Redmile Group
Rubric Capital Management
Squadron Capital Management
Ally Bridge Group
Partner Fund Management
Ameriprise Financial
Woodline Partners

View all funds holding Eupraxia Pharmaceuticals